Ensign Peak Advisors’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$44.8M Buy
573,001
+135,611
+31% +$10.9M 0.07% 205
2026
Q1
$37.9M Buy
437,390
+46,360
+12% +$4.44M 0.07% 217
2025
Q4
$37.6M Sell
391,030
-66,012
-14% -$6.41M 0.07% 216
2025
Q3
$43.5M Sell
457,042
-356,083
-44% -$32.7M 0.07% 217
2025
Q2
$70.9M Sell
813,125
-46,085
-5% -$3.91M 0.12% 155
2025
Q1
$77.2M Buy
859,210
+513,314
+148% +$45.9M 0.15% 139
2024
Q4
$27.6M Sell
345,896
-25,378
-7% -$2.2M 0.05% 266
2024
Q3
$33.4M Sell
371,274
-17,355
-4% -$1.46M 0.06% 232
2024
Q2
$30.6M Buy
388,629
+21,545
+6% +$1.77M 0.06% 240
2024
Q1
$32M Buy
367,084
+16,566
+5% +$1.41M 0.06% 240
2023
Q4
$28.9M Sell
350,518
-34,151
-9% -$2.6M 0.06% 258
2023
Q3
$30.1M Sell
384,669
-388,620
-50% -$32.5M 0.06% 224
2023
Q2
$68.1M Sell
773,289
-67,766
-8% -$5.83M 0.14% 136
2023
Q1
$67.8M Sell
841,055
-184,952
-18% -$15.1M 0.15% 141
2022
Q4
$79.7M Sell
1,026,007
-69,672
-6% -$5.65M 0.18% 120
2022
Q3
$88.5M Sell
1,095,679
-77,444
-7% -$6.96M 0.22% 98
2022
Q2
$105M Buy
1,173,123
+30,413
+3% +$3.08M 0.25% 99
2022
Q1
$127M Sell
1,142,710
-140,754
-11% -$14.9M 0.26% 91
2021
Q4
$133M Buy
1,283,464
+163,865
+15% +$19M 0.25% 90
2021
Q3
$140M Buy
1,119,599
+45,208
+4% +$5.85M 0.29% 87
2021
Q2
$133M Sell
1,074,391
-3,406
-0.3% -$428K 0.27% 98
2021
Q1
$127M Buy
1,077,797
+59,134
+6% +$6.93M 0.27% 94
2020
Q4
$119M Buy
1,018,663
+285,616
+39% +$31.4M 0.27% 94
2020
Q3
$76.2M Buy
733,047
+45,819
+7% +$4.6M 0.19% 102
2020
Q2
$63M Buy
687,228
+36,458
+6% +$3.5M 0.17% 110
2020
Q1
$58.7M Buy
650,770
+135,395
+26% +$14.4M 0.2% 97
2019
Q4
$58.5M Buy
+515,375
New +$56.6M 0.15% 113

Other funds holding MDT

Ensign Peak Advisors's MDT Position: Q2 2026 in Review

Ensign Peak Advisors increased its Medtronic (MDT) stake by 31% in Q2 2026, buying an estimated $10.9M and bringing the position to 573,001 shares worth $44.8M. The position accounts for 0.07% of the portfolio, ranked #205.

Ensign Peak Advisors first reported a position in MDT in Q4 2019 and has held it in 27 quarters since. The position peaked at $140M in Q3 2021. 2,124 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Ensign Peak Advisors held 573,001 shares of Medtronic worth $44.8M as of Q2 2026.
  • Ensign Peak Advisors bought 135,611 Medtronic shares in Q2 2026, an estimated $10.9M.
  • Medtronic made up 0.07% of Ensign Peak Advisors's portfolio in Q2 2026, its #205 holding.
  • Ensign Peak Advisors first reported a position in Medtronic in Q4 2019 and has held it in 27 quarters since.
  • Ensign Peak Advisors's Medtronic position peaked at $140M in Q3 2021.
  • 2,124 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Ensign Peak Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.